Levi Strauss, VBI Vaccines And 3 Stocks To Watch Heading Into Thursday
Portfolio Pulse from Lisa Levin
Levi Strauss & Co., Vimeo, Inc., Kura Sushi USA, Inc., VBI Vaccines Inc., and Trinity Biotech plc are the stocks to watch heading into Thursday. Levi Strauss is expected to post quarterly earnings of 3 cents per share on revenue of $1.34 billion. Vimeo announced the departure of its CEO, Anjali Sud, and named Adam Gross as interim CEO. Kura Sushi is expected to have earned 13 cents per share on revenue of $49.57 million. VBI Vaccines announced the expansion of their hepatitis B partnership and a proposed public offering. Trinity Biotech is expected to report a quarterly loss of 6 cents per share on revenue of $18.50 million.
July 06, 2023 | 8:18 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
VBI Vaccines announced the expansion of their hepatitis B partnership and a proposed public offering.
The announcement of a public offering can often lead to a short-term decrease in stock price due to potential dilution of shares.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Vimeo announced the departure of its CEO, Anjali Sud, and named Adam Gross as interim CEO.
CEO departures can create uncertainty and potentially negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEUTRAL IMPACT
Kura Sushi is expected to have earned 13 cents per share on revenue of $49.57 million.
The expected earnings report could influence the stock price depending on whether the actual results meet, exceed, or fall short of expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Levi Strauss is expected to post quarterly earnings of 3 cents per share on revenue of $1.34 billion.
The expected earnings report could influence the stock price depending on whether the actual results meet, exceed, or fall short of expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Trinity Biotech is expected to report a quarterly loss of 6 cents per share on revenue of $18.50 million.
The expected earnings report could influence the stock price depending on whether the actual results meet, exceed, or fall short of expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100